Article (Published version) (149 Kb) - 
Limited access to UNIGEOther version: https://journals.lww.com/transplantjournal/Fulltext/2019/01000/Should_Patients_With_NAFLD_NASH_Be_Surveyed_for.13.aspx
Highlights
Scientific Article
unige:114608 
 |
Should Patients With NAFLD/NASH Be Surveyed for HCC? |
|
| Authors | ||
| Published in | Transplantation. 2019, vol. 103, no. 1, p. 39-44 | |
| Abstract | Patients with nonalcoholic fatty liver disease (NAFLD) are at risk of developing hepatocellular carcinoma (HCC), but the magnitude of the association still needs to be determined to define the need for a specific surveillance strategy. | |
| Identifiers | PMID: 30080818 | |
| Full text |
Article (Published version) (149 Kb) - Limited access to UNIGE Other version: https://journals.lww.com/transplantjournal/Fulltext/2019/01000/Should_Patients_With_NAFLD_NASH_Be_Surveyed_for.13.aspx |
|
| Structures | ||
| Research group | Transplantation et hépatologie (905) | |
| Project | FNS: PP00P3_165837 | |
| Citation (ISO format) | REIG, Maria et al. Should Patients With NAFLD/NASH Be Surveyed for HCC?. In: Transplantation, 2019, vol. 103, n° 1, p. 39-44. doi: 10.1097/TP.0000000000002361 https://archive-ouverte.unige.ch/unige:114608 |
216 hits 
0 download 
Contact an author
Update